<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>(A) Repurposing drugs to treat COVID 19. (B) Combinations of drugs used in the SOLIDARITY project by WHO.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">CAS/RN</th>
    <th align="left">Drug candidate</th>
    <th align="left">Target molecule</th>
    <th align="left">Mode of action</th>
    <th align="left">Drug originally used for</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" colspan="5">A</td>
   </tr>
   <tr>
    <td align="left"> 1187594-09-7</td>
    <td align="left">Baricitinib</td>
    <td align="left">JAK kinase</td>
    <td align="left">A JAK inhibitor that may interfere with the inflammatory processes</td>
    <td align="left">Rheumatoid arthritis</td>
   </tr>
   <tr>
    <td align="left"> 206361-99-1</td>
    <td align="left">Darunavir</td>
    <td align="left">Aspartyl protease inhibitor</td>
    <td align="left">Interface with viral replication</td>
    <td align="left">Hepatitis C, Ebola virus, Marburg virus</td>
   </tr>
   <tr>
    <td align="left"> 36791-04-5</td>
    <td align="left">Ribavirin</td>
    <td align="left">Inosine monophosphate dehydrogenase</td>
    <td align="left">Inhibition of Inosine monophosphate dehydrogenase(induction of mutagenesis)</td>
    <td align="left">RSV infection, hepatitis C, some viral hemogrrhagic fevers</td>
   </tr>
   <tr>
    <td align="left"> 259793-96-9</td>
    <td align="left">Favipiravir</td>
    <td align="left">RdRp</td>
    <td align="left">A puirne nucleoside that acts as an alternative substrate leading to inaccurate viral RNA synthesis</td>
    <td align="left">Viral infections</td>
   </tr>
   <tr>
    <td align="left"> 131707-23-8</td>
    <td align="left">Arbidol</td>
    <td align="left">S protein/ACE2</td>
    <td align="left">An inhibitor that may disrupt that binding of viral envelope protein to host cells and prevent viral entry to the target cell</td>
    <td align="left">Influenza anti viral</td>
   </tr>
   <tr>
    <td align="left"> 55981-09-4</td>
    <td align="left">Nitazoxanide</td>
    <td align="left">Oxidative phosphorylation in mitochondria</td>
    <td align="left">A drug that may inhibit viral protein expression</td>
    <td align="left">Various helminthic, protozoal, and viral infection-caused diarrhoea</td>
   </tr>
   <tr>
    <td align="left" colspan="5">B</td>
   </tr>
   <tr>
    <td align="left">
     <p> 54-05-7</p>
     <p> 118-42-3</p>
    </td>
    <td align="left">
     <p>Chloroquine</p>
     <p>Hydroxchloroquine</p>
    </td>
    <td align="left">Endosome or ACE2</td>
    <td align="left">A drug that can elevate endosomal pH and interfere with ACE2 glycosylation</td>
    <td align="left">Material parasite infection</td>
   </tr>
   <tr>
    <td align="left">
     <p> 192725-17-0</p>
     <p> 155213-67-3</p>
    </td>
    <td align="left">
     <p>Lopinavir</p>
     <p>Ritonavir</p>
    </td>
    <td align="left">3CLpro &amp; PLpro- viral proteases</td>
    <td align="left">Protease inhibitors that may inhibit the viral protease: 3CLpro or PLpro</td>
    <td align="left">Used in combination for HIV virus treatment</td>
   </tr>
   <tr>
    <td align="left"> 1809249-37-3</td>
    <td align="left">Remdesivir</td>
    <td align="left">Act as nucleotide analogue</td>
    <td align="left">A nucleotide analogue that may block viral nucleotide synthesis to stop viral replication</td>
    <td align="left">Ebola virus infection</td>
   </tr>
   <tr>
    <td align="left"> 145258-61-3</td>
    <td align="left">
     <p>Interferon beta-1a</p>
     <p>(used in combination with Lopinavir and Ritonavir)</p>
    </td>
    <td align="left">Molecules of innate and adaptive immune system</td>
    <td align="left">Supress T cell activation, activates macrophages that engulf antigens and NK cells, activates different immunomodulators and antiviral proteins</td>
    <td align="left">Multiple sclerosis</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
